Hyperleukocytic Leukemias and Leukostasis: A Review of Pathophysiology, Clinical Presentation and Management
Top Cited Papers
- 1 January 2000
- journal article
- review article
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 39 (1-2), 1-18
- https://doi.org/10.3109/10428190009053534
Abstract
Acute hyperleukocytic leukemias (AHL) are associated with a very high early mortality rate mostly due to respiratory failure or intracranial bleeding. The pathophysiological process leading to these complications is called leukostasis but the biological mechanisms underlying its development and progression remain unclear. Although traditionally related to "over-crowding" of leukemic blasts in the capillaries of the microcirculation, leukostasis is likely to result from direct endothelial cell damage. This damage is probably mediated by soluble cytokines released during the interaction between leukemic cells and vascular endothelium and by the subsequent migration of leukemic blasts in the perivascular space. Leukemic cell's ability to respond to chemotactic cytokines and their expression of specific adhesion molecules are probably more important in determining whether leukostasis will develop than the number of circulating blasts. This could explain why leukostasis does not develop in all patients with AHL. The identification of the adhesion molecules, cytokines and receptors mediating endothelial cell damage in AHL should become a priority if therapeutic improvements are desired. Leukapheresis is widely used but it is unclear whether it provides additional benefit to a simpler and less invasive intervention with allopurinol, hydroxyurea and intravenous fluids. Cranial irradiation is not generally recommended. Induction chemotherapy should be started without delay. It is hoped that specific pharmacological inhibitors of the interaction between leukemic cells and vascular endothelium will result in an improved outcome for this very high-risk population.Keywords
This publication has 101 references indexed in Scilit:
- Indications for Emergency Apheresis ProceduresCritical Reviews in Clinical Laboratory Sciences, 1997
- Acute lymphoblastic leukemia a comprehensive review with emphasis on biology and therapyCancer, 1995
- 5 Hyperleukocytic leukaemia: rheological and clinical features and managementBailliere's Clinical Haematology, 1987
- Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte countCancer, 1983
- Continuous‐Flow Leukapheresis for Rapid Cytoreduction in LeukemiaTransfusion, 1980
- Reversible respiratory failure due to intravascular leukostasis in chronic myelogenous leukemia: Relationship of oxygen transfer to leukocyte countAmerican Journal Of Medicine, 1979
- Rapid Cytoreduction in Acute LeukemiaTransfusion, 1978
- FACTORS EFFECTING REMISSION AND SURVIVAL IN ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)Medicine, 1970
- A distinctive type of intracerebral hemorrhage associated with “blastic crisis” in patients with leukemiaCancer, 1960
- The Association of Fatal Intracranial Hemorrhage and Blastic Crisis in Patients with Acute LeukemiaThe New England Journal of Medicine, 1959